Résumé
Introducción: la falta de adherencia farmacológica, siendo un problema de salud pública es una de las principales causas de incremento de la morbimortalidad, discapacidad y costos sanitarios en los pacientes con enfermedades crónicas no transmisibles. Objetivo: describir la prevalencia de la no adherencia al tratamiento farmacológico de los pacientes adultos con patología crónica que asistieron a un centro médico de la ciudad de Tunja, desde septiembre a noviembre del año 2022. Materiales y métodos: estudio observacional de corte transversal que incluyó adultos mayores de 18 años con enfermedad crónica no transmisible en el servicio de consulta externa de un centro de salud de baja complejidad, se recolectó los datos de las historias clínicas, se utilizó estadística descriptiva y Odds Ratio para análisis de asociación. Resultados: se analizaron 216 pacientes. La prevalencia de no adherencia al tratamiento farmacológico fue del 75%, el promedio de edad de pacientes con patología crónica fue 65,5 años, el sexo femenino representó el 56,9%, la mayoría de los casos tuvieron hipertensión arterial sistémica (94,4%), más de la mitad presentaron comorbilidades (73,1%) y el 45,3% estaban polimedicados. Los factores relacionados con la no adherencia farmacológica según el test de Morisky-Green fueron edad menor a 60 años (p=0,033), sexo masculino (p=0,045), consumo de alcohol (p=0,003) y tabaco (p=0,003), ausencia de comorbilidades (p=0,008) y no polifarmacia (p=0,004). Conclusión: la no adherencia farmacológica presentó una prevalencia, por encima a la reportada en la literatura y el principal factor asociado fue el consumo de tabaco. Los resultados obtenidos proporcionan conocimientos para nuevas investigaciones (AU)
Introduction: lack of pharmacological adherence, being a public health problem, is one of the main causes of increased morbidity and mortality, disability and health costs in patients with chronic non-communicable diseases. Objective: to describe the prevalence of non-adherence to pharmacological treatment in adult patients with chronic pathology who attended a medical center in the city of Tunja, from September to November 2022. M aterials and methods: cross-sectional observational study that included adults over 18 years of age with chronic non-communicable disease in the outpatient service of a low-complexity health center, data was collected from medical records, descriptive statistics were used and Odds Ratio for association analysis. Results: 216 patients were analyzed. The prevalence of non-adherence to pharmacological treatment was 75%, the average age of patients with chronic pathology was 65.5 years, the female sex represented 56.9%, the majority of cases had systemic arterial hypertension (94,4%), more than half had comorbidities (73.1%) and 45.3% were polypharmacy. The factors related to pharmacological non-adherence according to the Morisky-Green test were age under 60 years (p=0.033), male sex (p=0.045), alcohol consumption (p=0.003) and tobacco (p=0.003), absence of comorbidities (p=0.008) and no polypharmacy (p=0.004). Conclusion: pharmacological non-adherence had a high prevalence above that reported in the literature and the main associated factor was tobacco consumption. The results obtained provide knowledge for new research (AU)
Sujets)
Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Sujet âgé , Sujet âgé de 80 ans ou plus , Maladie chronique , Adhésion au traitement médicamenteux/statistiques et données numériques , Comorbidité , Enquêtes et questionnaires , Établissements de santéRésumé
Abstract To assess the therapy relative to indication, effectiveness, safety and adherence in patients with Alzheimer's disease (AD). An interventional, prospective, non-randomized study was conducted in a single secondary care center in Brazil. The pharmacist-led medication therapy management (MTM) was conducted to detect drug-related problems (DRPs) at baseline and after six months of intervention. The health status outcomes (i.e. cognitive screening tests; levels of glucose; total cholesterol; triglycerides; thyroid stimulating hormone; serum free thyroxine and blood pressure) were measured. 66 patients with AD were included, of whom 55 patients completed the follow-up of six months. 36 patients (36/55) were non-adherent to AD drug therapy. Out of detected 166 DRPs, 116 were solved. Four patients were withdrawn from the AD protocol due to resolution of prodromal symptoms. On the conclusion of the study, the MTM improved and controlled blood pressure, glucose, total cholesterol, triglycerides levels (p<0.05). The pharmacist-led MTM was effective in solving 69.8% of DRPs, improving and controlling the clinical parameters evaluated
Sujets)
Humains , Mâle , Femelle , Adulte d'âge moyen , Sujet âgé , Sujet âgé de 80 ans ou plus , Patients/classification , Pharmaciens/classification , Maladie d'Alzheimer/anatomopathologie , Sujet âgé , Adhésion au traitement médicamenteux/statistiques et données numériques , Bilan de médication , Erreurs de médication/statistiques et données numériquesRésumé
Introduction: Glycemic decompensation in diabetes is one of the major factors for the development of chronic disease complications. Factors involved in the adequate control of diabetes include adherence to pharmacological treatment and knowledge about the disease.Methods: Cross-sectional study on the factors associated with adherence to drug treatment and knowledge about diabetes in diabetic patients treated at Hospital Universitário de Santa Maria between 2018 and 2019, based on the validated Morisky-Green test and on the Diabetes Knowledge Questionnaire.Results: A total of 201 patients diagnosed with diabetes were included, the majority (85.6%) of which had type 2 diabetes and were white (75.6%), with a mean age of 59.4 years. An association between insufficient knowledge about diabetes and patients with type 2 diabetes was observed. An association was found between patients with type 2 diabetes using insulin and non-adherence to drug treatment compared with patients with type 2 diabetes who did use insulin. The research also showed that non-adherence to drug treatment was associated with higher occurrence of hypoglycemia compared with patients who adhered to drug treatment.Conclusion: The data obtained in our study allows us to conclude that non-adherence to pharmacological treatment makes diabetes therapy more complicated and worsens the prognosis.
Sujets)
Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Sujet âgé , Sujet âgé de 80 ans ou plus , Jeune adulte , Complications du diabète/complications , Adhésion au traitement médicamenteux/psychologie , Adhésion et observance thérapeutiques/psychologie , Régulation de la glycémie/statistiques et données numériques , Diabète/anatomopathologie , Diabète/traitement médicamenteux , Adhésion au traitement médicamenteux/statistiques et données numériquesRésumé
Abstract To evaluate the prevalence of self-reported drug adherence and factors associated, as well as clinical health outcomes, for industry workers with hypertension (HTN) and diabetes mellitus (DM). This was a cross-sectional study of 137 Brazilian industry workers with HTN and/ or DM. Self-reported adherence was assessed, and the disease control was defined through blood pressure and capillary glycemia values. Data were descriptively analyzed and the factors associated with adherence were evaluated using the Poisson model with robust variance to calculate prevalence ratios. The prevalence of self-reported drug adherence was 79.6% and the prevalence of disease control was 53.8%. There was no statistically significant association between the two variables. In the controlled disease group, non-adherence was associated with being under 40 years of age, not having a partner, and having a risky alcohol consumption habit. In the uncontrolled disease group, adherence was highest for participants aged 40 years and older. The prevalence of self-reported drug adherence was high, but the prevalence of disease control was low and not associated with adherence, indicating that the self-reported adherence measure may be inaccurate. Our findings identify some factors that explain non-adherent behavior in the workforce.
Sujets)
Humains , Mâle , Femelle , Adolescent , Adulte , Adulte d'âge moyen , Diabète/traitement médicamenteux , Adhésion au traitement médicamenteux/statistiques et données numériques , Hypertension artérielle/traitement médicamenteux , Industrie , Brésil , Prévalence , Études transversales , AutorapportRésumé
Este estudo teve por objetivo reunir evidências científicas sobre o papel dos fatores sociodemográficos na adesão aos anti-hipertensivos na Atenção Primária à Saúde (APS) no Brasil. Trata-se de uma revisão integrativa com estudos publicados entre 2015 e 2019 em periódicos nacionais. Foram incluídos artigos originais desenvolvidos com hipertensos usuários da APS no Brasil e foram excluídos artigos publicados fora do intervalo temporal citado, bem como revisões de literatura, e os que não tinham como foco os elementos de interesse nesta revisão. Foram selecionados 5 estudos que investigaram variáveis sociodemográficas no contexto da adesão a esta classe de medicamentos na APS. Embora alguns estudos tenham encontrado uma possível interferência de algumas variáveis sociodemográficas na adesão aos anti-hipertensivos na Atenção Básica, há, para cada uma dessas variáveis, resultados divergentes, mostrando que a dimensão sociodemográfica pode ou não interferir na adesão à medicação em um determinado grupo populacional. Nesse sentido, há também resultados sugestivos de que, com oferta efetiva de assistência aos usuários, tais variáveis parecem perderem capacidade de interferirem nesta adesão, em consonância com a hipótese de que características organizacionais dos serviços de saúde têm impacto muito maior na adesão do que diferenças sociodemográficas.
This study aimed to gather scientific evidence on the role of sociodemographic factors in adherence to antihypertensive drugs in Primary Health Care (PHC)_in Brazil. This is an integrative review with studies published between 2015 and 2019 in national journals. Original studies developed with hypertensive PHC users in Brazil were included and articles published outside the time range were excluded, as well as literature reviews, and those that did not focus on the elements of interest of this review. A total of 5 studies that investigated sociodemographic variables in the context of adherence to this class of drugs in PHC were selected. Although some studies have found a possible interference of some sociodemographic variables in adherence to antihypertensive drugs in Primary Care, there are, for each of these variables, divergent results, showing that the sociodemographic dimension may or may not interfere with medication adherence in a given population group. In this sense, there are also results suggesting that, with effective provision of assistance to users, such variables seem to lose their interference capacity in user adherence, in line with the hypothesis that organizational characteristics of health services have a much greater impact on adherence than sociodemographic differences.
Sujets)
Humains , Sujet âgé , Sujet âgé de 80 ans ou plus , Adhésion au traitement médicamenteux/statistiques et données numériques , Antihypertenseurs/usage thérapeutique , Hypertension artérielle/prévention et contrôle , Hypertension artérielle/traitement médicamenteuxRésumé
Objetivo: Elaborar um perfil clínico e epidemiológico de pacientes com insuficiência cardíaca descompensada, de acordo com a etiologia da descompensação, e analisar o desfecho clínico dentre os diferentes grupos etiológicos encontrados. Métodos: Estudo retrospectivo e observacional. Os pacientes foram reunidos em seis grupos, conforme etiologia de descompensação, e comparados de acordo com dados coletados. Realizaram-se verificação por meio da análise de variância e teste exato de Fisher. Obteve-se significância estatística por meio do valor de p <0,10. Resultados: Foram analisados 123 prontuários de pacientes admitidos entre 2016 e 2018. A maior causa de descompensação da doença foi a má aderência ao tratamento (32,5%). Além disso, a doença foi responsável por maior tempo de internação (13,5 dias) e número de óbitos (seis). Conclusão: Otimizando-se os cuidados e o acompanhamento desses pacientes, pode haver um importante impacto sobre a incidência, as complicações e a frequência de descompensações. (AU)
Objective: To develop a clinical and epidemiological profile of patients with decompensated heart failure according to the etiology of decompensation and to analyze the clinical outcome among the different etiological groups found. Methods: This is a retrospective, observational study. Patients were divided in six groups according to etiology of decompensation and were compared according to data collected. Variance analysis and Fisher's exact test were performed. Statistical significance was obtained by means of p-value <0.10. Results: We analyzed 123 medical records of patients admitted between 2016 and 2018. The greatest cause of decompensation was the poor adherence to treatment (32.5%). In addition, the disease was responsible for longer hospitalization time (13.5 days) and number of deaths (six). Conclusion: Optimizing care and follow-up of these patients can have an important impact on the incidence, complications, and frequency of decompensation. (AU)
Sujets)
Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Sujet âgé , Profil de Santé , Défaillance cardiaque/épidémiologie , Hôpitaux d'enseignement/statistiques et données numériques , Troubles du rythme cardiaque/complications , Brésil/épidémiologie , Épidémiologie Descriptive , Études rétrospectives , Répartition par sexe , Répartition par âge , Syndrome coronarien aigu/complications , Adhésion au traitement médicamenteux/statistiques et données numériques , Dossiers médicaux électroniques , Défaillance cardiaque/diagnostic , Défaillance cardiaque/étiologie , Défaillance cardiaque/sang , Hospitalisation , Hypertension artérielle/complications , Infections/complicationsRésumé
Objetivo: Avaliar a adesão ao tratamento e a qualidade de vida de pacientes diabéticos e identificar características epidemio- lógicas e da doença relacionadas. Métodos: Estudo transversal realizado com 98 pacientes diabéticos em acompanhamento. Foram aplicados: um questionário sociodemográfico; o Diabe- tes Quality of Life na versão brasileira, para avaliar qualidade de vida, e o teste Morisky-Green-Levine, para checar a adesão ao tratamento. O nível de significância adotado foi de 5%. Resul- tados: A maioria (87,8%) dos pacientes apresentou boa quali- dade de vida. O escore médio de qualidade de vida foi de 2,2. Existência de complicações, uso de insulina e má adesão ao tra- tamento foram fatores associados à pior qualidade de vida. A boa adesão ao tratamento (58,2%) foi associada à boa qualidade de vida (p<0,001). Conclusão: A boa adesão ao tratamento está relacionada à boa qualidade de vida. Deve-se enfatizar a impor- tância da adesão ao tratamento para prevenção de possíveis com- plicações e manutenção da qualidade de vida.
Objective: To evaluate adherence to treatment and quality of life of diabetic patients and to identify related epidemiological and disease characteristics. Methods: Cross-sectional study conducted with 98 diabetic patients undergoing treatment. A socio-demographic questionnaire, the Diabetes Quality of Life in the Brazilian version (to measure quality of life) and the Mo- risky-Green-Levine test (to check adherence to treatment) were applied. The level of significance was set at 5%. Results: Most patients (87.8%) showed good quality of life. The mean score of quality of life was 2.2. The existence of complications, insulin use, and poor treatment adherence were factors associated with worse quality of life. Good adherence to treatment, (58.2%) was associated with good quality of life (p<0.001). Conclusion: Satis- factory treatment adherence is associated with good quality of life. The importance of adherence to treatment to prevent possible complications and maintain quality of life shall be emphasized.
Sujets)
Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Sujet âgé , Sujet âgé de 80 ans ou plus , Jeune adulte , Qualité de vie , Diabète/épidémiologie , Adhésion au traitement médicamenteux/statistiques et données numériques , Facteurs socioéconomiques , Brésil/épidémiologie , Études transversales , Enquêtes et questionnaires , Répartition par sexe , Répartition par âge , Complications du diabète , Diabète/traitement médicamenteux , Facteurs sociodémographiques , Services de santé , Hypoglycémiants/usage thérapeutique , Insuline/usage thérapeutiqueRésumé
Abstract The purpose of this review was to identify interventions that improve adherence to medications in patients with ulcerative colitis (UC). The literature search was carried out between April and June 2020 in the PubMed/MEDLINE database, with the combination of MeSH terms medication adherence; intervention; ulcerative colitis; and inflammatory bowel disease.We restricted our search to articles published in English and Portuguese between March 2010 and March 2020. After the selection, recovery of fulltext articles and analysis of the defined criteria, the interventions described in the studies were classified into four domains: educational; behavioral, cognitive behavioral, and multicomponent. In total, six clinical trials met the inclusion criteria and were analyzed. Half of the studies (3; 50%) used multicomponent interventions, 2 (33.3%) focused on behavioral interventions, and 1 (16.7%) applied isolated educational interventions. All studies used indirect methods to measure adherence, with an emphasis on scales and questionnaires. Half of the studies (3; 50%) showed a positive impact on adherence in patients with UC, with evidence that multicomponent interventions, when properly implemented in a clinical trial combining direct and indirect methods to measure medication adherence, appear to increase the chances of better results. We believe that future studies focusing on improving adherence in patients with UC are necessary.
Resumo O objetivo desta revisão foi identificar intervenções para a melhoria da adesão a medicamentos em pacientes com colite ulcerativa (CU). A busca na literatura foi realizada entre abril e junho de 2020 na base de dados do PubMed/MEDLINE, com a combinação dos descritores medication adherence; intervention; ulcerative colitis; e inflammatory bowel disease. Restringimos a busca aos artigos publicados em inglês e português entre março de 2010 e março de 2020. Após a seleção, recuperação dos textos dos artigos, e análise dos critérios definidos, as intervenções descritas nos estudos foram classificadas em quatro domínios: educacional; comportamental, cognitivo comportamental, e multicomponente. No total, seis ensaios clínicos atenderam aos critérios de inclusão e foram analisados. Metade dos estudos (3; 50%) usaram intervenções do tipo multicomponente, 2 (33.3%) centraram-se em intervenções comportamentais, e 1 (16.7%) aplicou intervenções educacionais isoladamente. Todos os estudos utilizaram métodos indiretos para mensurar a adesão, comênfase em escalas e questionários. Metade dos estudos (3; 50%) demonstraram impacto positivo na adesão em pacientes com CU, com indícios de que intervenções do tipo multicomponente, quando apropriadamente implementadas em ensaio clínicos que associam métodos diretos e indiretos para a mensuração da adesão a medicamentos, parecem aumentar as chances de melhores resultados. Consideramos que estudos futuros centrados na melhoria da adesão em pacientes com CU se fazem necessários.
Sujets)
Humains , Mâle , Femelle , Rectocolite hémorragique/traitement médicamenteux , Adhésion au traitement médicamenteux/statistiques et données numériques , Gestion de soi/statistiques et données numériquesRésumé
Objetivo: Analisar os fatores de risco para o abandono do tratamento da tuberculose no município de Porto Velho RO, no período de 2010 a 2015. Método: Estudo descritivo, transversal e quantitativo dos dados coletados no Sistema de Notificação de Agravos Nacional de todos os portadores de tuberculose que abandonaram o tratamento no município. Análise foi realizada através de distribuição de frequência, após atender os preceitos éticos. Resultados: Pertencer ao sexo masculino (73,6%), média de idade de 34,8 anos, cor/raça parda (70,2%), baixa escolaridade (35,1%), desemprego (8,9%), caso novo (64,3%), forma clínica pulmonar (87,4%), raio-x suspeito (75%), baciloscopia de escarro positiva (62,5%), exames de controle mensal não realizados/ em branco, aproximadamente quatro meses de tratamento e não ser acompanhado pelo regime do Tratamento Diretamente Observado, constituíram como fatores de risco para o abandono. Conclusão: Evidencia-se a necessidade de ações sobre estes fatores, para fornecer subsídios para o controle da doença
Objective: to analyze the risk factors for the abandonment of tuberculosis treatment in the municipality of Porto Velho - RO, from 2010 to 2015. Methods: a descriptive, cross-sectional and quantitative study of the data collected in the National Disease Notification System of all tuberculosis patients who abandoned treatment in the municipality. Analysis was performed through frequency distribution, after meeting the ethical precepts. Results: male (73.6%), mean age 34.8 years, brown color/ race (70.2%), low schooling (35.1%), unemployment (8.9%), new case (64.3%), pulmonary clinical form (87.4%), suspected x-ray (75%), sputum smear positive (62.5%), monthly checkups unconcluded/ blank monthly control tests four months of treatment and not being accompanied by the Directly Observed Treatment regimen, were considered as risk factors for abandonment. Conclusion: the need for action on these factors is evidenced, in order to provide subsidies for the control of the disease
Objetivo: analizar los factores de riesgo para el abandono del tratamiento de la tuberculosis en el municipio de Porto Velho - RO, en el período de 2010 a 2015. Método: estudio descriptivo, transversal y cuantitativo de los datos recogidos en el Sistema de Notificación de Agravios Nacional de todos los portadores de tuberculosis que abandonaron el tratamiento en el municipio. El análisis fue realizado a través de la distribución de frecuencia, después de atender los preceptos éticos. Resultados:pertenencia al sexo masculino (73,6%), promedio de edad de 34,8 años, color/ raza parda (70,2%), baja escolaridad (35,1%), desempleo (8,9%), caso nuevo (64,3%), forma clínica pulmonar (87,4%), radiografía sospechosa (75%), baciloscopia de esputo positivo (62,5%), exámenes de control mensual no realizados/ en blanco, aproximadamente cuatro meses de tratamiento y no ser acompañado por el régimen del Tratamiento Directamente Observado, constituyeron como factores de riesgo para el abandono. Conclusión: se evidencia la necesidad de acciones sobre estos factores, a fin de proporcionar subsidios para el control de la enfermedad
Sujets)
Humains , Mâle , Femelle , Abandon des soins par les patients/statistiques et données numériques , Tuberculose/épidémiologie , Adhésion au traitement médicamenteux/statistiques et données numériques , Facteurs de risqueRésumé
ABSTRACT Objective: To investigate knowledge of caregivers of children with congenital hypothyroidism (CH), followed in a public reference service, as well as their associations with treatment adherence. Methods: Exploratory, descriptive, cross-sectional study with convenience sample. Medical records of 158 patients diagnosed with congenital hypothyroidism were analyzed, and data were evaluated by applying a previously prepared questionnaire to caregivers from 2014 to 2016. Statistical analysis used the chi-square and the Spearman's correlation tests, being significant p-value ≤0.05. Results: Females were predominant among caregivers (94.3%), with a mean age of 31 years, from inland cities (77.8%). There was a predominance of socioeconomic class C (59.5%) and incomplete primary education (35.7%). More than half of patients (53.2%) with CH had an adequate hormonal control. Approximately one third of caregivers had poor knowledge (37.3%) or was unaware (24.1%) about the meaning of congenital hypothyroidism. The low knowledge level of the disease was observed to be related to caregivers' educational level (p=0.004). Conclusions: Lack of education of caregivers was a barrier to be faced when monitoring children with CH. This reality requires greater attention from health professionals to ensure that they use clear language when giving instructions to caregivers, and that caregivers have adequately understood the proposed recommendations.
RESUMO Objetivo: Investigar o conhecimento dos cuidadores das crianças com hipotireoidismo congênito (HC) acompanhadas em um serviço público de referência, bem como as suas associações com a adesão ao tratamento. Métodos: Trata-se de um estudo exploratório, descritivo, de corte transversal, com amostra de conveniência. Foram analisados os prontuários de 158 pacientes com diagnóstico de HC e avaliados os dados obtidos pela aplicação de um questionário previamente elaborado, destinado aos cuidadores, durante o período de 2014 a 2016. A análise estatística foi feita com o teste do qui-quadrado e a Correlação de Spearman, para correlacionar a pontuação do questionário, sendo significante o valor de p≤0,05. Resultados: Os cuidadores eram predominantemente do sexo feminino (94,3%), com média de idade de 31 anos, proveniente de cidades do interior (77,8%). Verificou-se predomínio da classe socioeconômica C (59,5%) e ensino fundamental incompleto (35,7%) na amostra dos cuidadores. Metade dos pacientes (53,2%) apresentava controle hormonal adequado. Aproximadamente 1/3 dos cuidadores demonstraram conhecimento ruim (37,3%) ou até mesmo desconheciam (24,1%) o HC. Observou-se que o baixo nível de conhecimento da doença estava diretamente relacionado com o nível educacional dos cuidadores (p=0,004). Conclusões: Os achados sugerem que a falta de instrução dos cuidadores é uma barreira a ser enfrentada durante o acompanhamento de crianças com HC, o que requer uma maior atenção do profissional de saúde, para garantir uma linguagem clara e um entendimento adequado das recomendações propostas.
Sujets)
Humains , Mâle , Femelle , Grossesse , Nourrisson , Enfant d'âge préscolaire , Enfant , Adulte , Thyréostimuline/usage thérapeutique , Connaissances, attitudes et pratiques en santé , Aidants/normes , Hypothyroïdie congénitale/traitement médicamenteux , Adhésion au traitement médicamenteux/statistiques et données numériques , Études transversales , Enquêtes et questionnaires , Aidants/statistiques et données numériquesRésumé
Abstract Introduction The treatment of schizophrenia aims to reduce symptoms, improve quality of life and promote recovery from debilitating effects. Nonadherence to treatment is related to several factors and may lead to persistence of symptoms and relapse. Worldwide, the rate of nonadherence to treatment in individuals with schizophrenia is around 50%. Objectives To compare the clinical profile of nonadherent and adherent patients among individuals diagnosed with schizophrenia receiving treatment at psychosocial care centers in a city in southern Brazil. Method The clinical-epidemiological profile of patients with schizophrenia was retrospectively analyzed based on medical records entered into the system between January and December 2016, evaluating data at one-year follow-up. Results 112 patients were included. The disease was more prevalent in men; mean age was 40.5 years, being lower among men. Most of the sample had a low level of education, was unemployed/retired, did not have children and resided with relatives. The highest rate of diagnosis was among young adults. Psychotic symptoms were most frequently described, and the most commonly prescribed antipsychotic was haloperidol. The nonadherence rate was 15.2%; only one patient required admission to a psychiatric hospital. Among nonadherent patients, the mean time of attendance was 6 months; there were more nonadherent women than men. The most prevalent age range of nonadherence was 41-64 years. Psychosocial and clinical data were similar across the whole sample. Conclusion A nonadherence rate of 15.2% was found among individuals receiving treatment for schizophrenia, suggesting that psychosocial care centers were effective in treating and monitoring these patients.
Sujets)
Adolescent , Adulte , Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Jeune adulte , Schizophrénie/physiopathologie , Schizophrénie/traitement médicamenteux , Schizophrénie/épidémiologie , Neuroleptiques/usage thérapeutique , Adhésion au traitement médicamenteux/statistiques et données numériques , Brésil/épidémiologie , Études rétrospectivesRésumé
INTRODUCCIÓN: La resistencia antibiótica y una inadecuada adherencia terapéutica son fenómenos que favorecen la proliferación de la tuberculosis. Los cambios sociodemográficos nos desafían a conocer la realidad actual de la enfermedad a través de antecedentes que nos permitan contextualizar un nuevo escenario. OBJETIVO: Caracterizar el perfil biopsicosocial del paciente con tuberculosis y su relación con la adherencia terapéutica. MATERIAL Y MÉTODO: Estudio descriptivo, transversal, correlacional. Muestra de 90 pacientes tratados en 35 Centros de Salud Familiar de los Servicios de Salud de Iquique, Metropolitano Norte, Concepción y Reloncaví. RESULTADOS: los componentes biopsicosociales como edad, antecedentes de enfermedad mental, autoestima, situación sentimental, pertenencia a grupos de riesgo, alcoholismo, drogadicción y situación de calle presentaron una relación estadísticamente significación con la adherencia terapéutica. CONCLUSIONES: La caracterización biopsicosocial del paciente con tuberculosis visibiliza nuevos factores relacionados con la adherencia que deben ser considerados para una atención interdisciplinaria.
BACKGROUND: Antibiotic resistance and inadequate therapeutic adherence are phenomena that promote the proliferation of tuberculosis. Sociodemographic changes challenge us to know the real situation of the disease and allows us to contextualize a new scenario. OBJECTIVE: To characterize the biopsychosocial profile of the patient with tuberculosis and its relationship to therapeutic adherence. MATERIAL AND METHOD: Descriptive, cross-sectional, correlational study. Sample of 90 patients treated at 35 Family Health Centers from the following Chilean Public Health Services: Iquique, Metropolitan northern (Santiago), Concepción and Reloncaví. RESULTS: Biopsychosocial components such as age, history of mental illness, self-esteem, sentimental status, belonging to risk groups, alcoholism, drug addiction and homeless situation presented a statistically significant relationship with therapeutic adherence. CONCLUSIONS: The biopsychosocial characterization of the TB patient evidence a new adherence-related factors that should be considered for interdisciplinary care.
Sujets)
Humains , Mâle , Femelle , Adulte , Tuberculose/psychologie , Tuberculose/traitement médicamenteux , Adhésion au traitement médicamenteux/psychologie , Adhésion et observance thérapeutiques/psychologie , Concept du soi , Facteurs socioéconomiques , Groupes à Risque , , Chili , Santé de la famille , Études transversales , Enquêtes et questionnaires , Troubles liés à une substance/psychologie , Résistance bactérienne aux médicaments , Alcoolisme/psychologie , Adhésion au traitement médicamenteux/statistiques et données numériques , Adhésion et observance thérapeutiques/statistiques et données numériques , Corrélation de données , Antituberculeux/usage thérapeutiqueRésumé
Background: Lack of compliance with medication prescription is common among older adults and hamper an adequate management of chronic conditions. Aim: To study the association between health literacy and medication adherence in older adults with chronic diseases in Temuco, Chile. Material and Methods: The Health Literacy survey for Spanish-speaking Adults, MiniMental examination and the Morisky-Green test to assess compliance with medication prescription were applied to 119 older adults aged 60 to 88 years. Results: All participants had an adequate global cognitive performance; 24% had inadequate literacy, and 42% did not comply with medication prescription. There was a significant correlation between health literacy and medication adherence. Conclusions: Health literacy influences medication adherence in Chilean older adults.
Sujets)
Humains , Adulte d'âge moyen , Sujet âgé , Sujet âgé de 80 ans ou plus , Adhésion au traitement médicamenteux/statistiques et données numériques , Compétence informationnelle en santé/statistiques et données numériques , Chili , Maladie chronique , Enquêtes et questionnairesRésumé
SUMMARY The objective of this study was to verify the level of adherence to antiretroviral treatment and its associated factors. This is a descriptive cross-sectional study based on data retrieved from medical records. To achieve this, we used a questionnaire composed of sociodemographic and clinical information recorded from patients aged between thirteen and fifty-nine years who attended a specialized service from 2007 to 2014. The chi-square test was performed to verify the association of the outcome with the categorical variables. Continuous variables were compared through the Student t-test. Thirteen variables were analyzed in the bivariate model, resulting in the selection of the following variables to the multivariate model (p<0.20) age of discovery (p=0.12), age (p=0.14), skin color (p=0.12), level of education (p=0.03), time since HIV diagnosis (p<0.001) and AIDS case (p<0.001). Among the six variables selected for the multivariate model, cases of aids (p<0.001) remained significant. We concluded that having aids decreases the probability of non-adherence to antiretroviral treatment by 92%. These results indicate that symptomatic patients have better adherence to therapy.
RESUMO O objetivo deste estudo foi verificar os níveis de adesão ao tratamento antirretroviral e os fatores associados a ela. Trata-se de um estudo descritivo de delineamento transversal baseado em levantamento de prontuários. Para tanto, foi utilizado um questionário composto de informações sociodemográficas e clínicas de pacientes com idade entre 13 e 59 anos atendidos em um serviço de atendimento especializado nos anos de 2007 a 2014. Foi realizado o teste do Qui-quadrado para verificar a associação do desfecho com as variáveis categóricas. As variáveis contínuas foram comparadas pelo teste t de "Student" (dois grupos). Treze variáveis foram analisadas no modelo bivariado, sendo selecionadas para o modelo multivariado (p<0,20): idade de descoberta (p=0,12), idade (p=0,14), cor da pele (p=0,12), escolaridade (p=0,03), tempo de diagnóstico do HIV (p<0,001) e caso de aids (p<0,001). Das seis variáveis selecionadas para o modelo multivariado, permaneceu significante o fato de o paciente ter aids (p<0,001). Concluiu-se que ter aids reduz a probabilidade de não adesão ao tratamento antirretroviral em cerca de 92%. Os resultados indicam que o indivíduo que é sintomático adere melhor à terapia.
Sujets)
Humains , Mâle , Femelle , Adolescent , Adulte , Jeune adulte , Infections à VIH/traitement médicamenteux , Agents antiVIH/usage thérapeutique , Thérapie antirétrovirale hautement active/statistiques et données numériques , Adhésion au traitement médicamenteux/statistiques et données numériques , Facteurs socioéconomiques , Brésil , Études transversales , Enquêtes et questionnaires , Facteurs de risque , Observance par le patient , Adhésion au traitement médicamenteux/ethnologie , Adulte d'âge moyenRésumé
ABSTRACT Objective To describe antiretroviral treatment regimens prescribed and their compliance with the Clinical Protocol and Therapy Guidelines of the Ministry of Health for the management of HIV infection. Methods Observational and descriptive study. Secondary data of the state of Paraná (Brazil) on drugs, treatment regimens, lines of treatment and number of individuals on treatment, from January to June 2018, were accessed at the Antiretroviral Agents Logistic Control System. Combinations of antiretroviral drugs (treatment regimens) were compared according to the current Clinical Protocol and Therapy Guidelines and non-compliances were classified and quantified. Results In Paraná, 35,127 individuals with HIV were treated with 253 different treatment regimens. Of the prescribed regimens, 19.1% were first-line, 27.4% second-line and 48.5% third-line. Among non-compliances, the most prevalent were absence of association of protease inhibitors and ritonavir (42.8%), low efficacy triple therapy (36.9%), double therapy (26.1%), monotherapy (20.3%), and triple therapy of nucleoside analog reverse transcriptase inhibitors (17.1%). Conclusion Most individuals receiving HIV treatment in the state of Paraná are on treatment regimens established in the current Clinical Protocol and Therapy Guidelines, which contributes to successful therapy. However, associations not provided by the current Clinical Protocol and Therapy Guidelines were identified in the initial treatment lines, which could lead to ineffectiveness, virologic failure and viral resistance.
RESUMO Objetivo Descrever esquemas terapêuticos de antirretrovirais prescritos e sua conformidade com o Protocolo Clínico e Diretrizes Terapêuticas, do Ministério da Saúde, para manejo da infecção pelo HIV. Métodos Estudo observacional e descritivo. Os dados do estado do Paraná sobre medicamentos que compõem os esquemas terapêuticos, linhas de tratamento e número de pessoas em uso destes foram acessados no Sistema de Controle Logístico de Medicamentos Antirretrovirais no período de janeiro a junho de 2018. As combinações de antirretrovirais (esquemas terapêuticos) foram comparadas conforme o Protocolo Clínico e Diretrizes Terapêuticas vigente, e as inconformidades foram categorizadas e quantificadas. Resultados No Paraná, 35.127 pessoas com HIV foram tratadas com 253 esquemas terapêuticos distintos. Dentre os esquemas prescritos, 19,1% eram de primeira linha, 27,4% de segunda linha e 48,5% de terceira linha. Nas inconformidades, predominaram a não associação entre inibidores da protease e ritonavir (42,8%), terapia tripla de baixa eficiência (36,9%), terapia dupla (26,1%), monoterapia (20,3%) e terapia tripla de inibidores da transcriptase reversa análogos de nucleosídeos (17,1%). Conclusão Maior parte das pessoas em tratamento do HIV no Paraná utilizam esquemas terapêuticos previstos no Protocolo Clínico e Diretrizes Terapêuticas vigente, o que contribui para o sucesso terapêutico. Entretanto, associações não previstas foram identificadas nas linhas de tratamento iniciais, podendo ocasionar inefetividade, falha virológica e resistência viral.
Sujets)
Humains , Protocoles cliniques/normes , Adhésion aux directives/normes , Antirétroviraux/administration et posologie , Brésil , Infections à VIH/traitement médicamenteux , Agents antiVIH/administration et posologie , Agents antiVIH/usage thérapeutique , Adhésion aux directives/statistiques et données numériques , Antirétroviraux/usage thérapeutique , Association de médicaments/normes , Association de médicaments/statistiques et données numériques , Adhésion au traitement médicamenteux/statistiques et données numériquesRésumé
Resumo O objetivo do estudo foi compreender quais são os principais desafios para adesão ao tratamento antirretroviral em Moçambique na perspectiva dos profissionais de saúde que lidam com a temática do HIV/aids no país. O estudo é qualitativo, observacional e exploratório. Entrevistas semiestruturadas foram realizadas com 11 profissionais de saúde que prestam assistência em HIV/aids em sete das onze províncias do país. Os dados foram analisados por meio da técnica de análise do Discurso do Sujeito Coletivo. Os resultados foram categorizados em nove ideias centrais. Dentre os problemas mencionados pelos profissionais estão aspectos relacionados à cultura local, ao receio da revelação forçada do diagnóstico de HIV positivo a terceiros, à ausência de uma adequada compreensão sobre os benefícios do tratamento, à forma de organização dos serviços de saúde, a questões de gênero, a aspectos sociais como fome, dificuldades financeiras e problemas com transporte, dentre outros.
Abstract The goal of the study was to understand the main challenges for adherence to antiretroviral treatment in Mozambique from the perspective of health professionals who deal with HIV/AIDS. The study is qualitative, observational, and exploratory. Semi-structured interviews were conducted with 11 health professionals who provide HIV/AIDS assistance in seven of the country's eleven provinces. Data analysis was based on the Discourse of the Collective Subject. Results were categorized into nine central ideas. Among the problems mentioned by health professionals there are aspects related to culture, the fear of forced disclosure of HIV positive diagnosis, the absence of an adequate understanding of the benefits of treatment, the way health services are organized, gender issues, and social aspects such as hunger, financial difficulties and problems with transportation, among others.
Sujets)
Humains , Infections à VIH/traitement médicamenteux , Personnel de santé , Thérapie antirétrovirale hautement active , Adhésion au traitement médicamenteux/statistiques et données numériques , Facteurs socioéconomiques , Entretiens comme sujet , Facteurs Culturels , Recherche qualitativeRésumé
ABSTRACT Objective: To investigate the association between social support, adherence to HIV anti-retroviral therapy, and clinical and sociodemographic factors. Method: A cross-sectional study conducted from July 2016 to August 2018 in a specialized outpatient clinic in southern Brazil. Individual interviews were conducted for the application of the following instruments: Questionnaire for the Evaluation of Adherence to Anti-retroviral Treatment (CEAT-HIV) and Social Support Scale for People Living with HIV/AIDS. The Spearman bivariate correlation test was used for analysis purposes. Results: Among the 168 participants, the mean social support score was 3.53 points (SD = 0.66), and 64.9% (n = 109) of the respondents had insufficient adherence. There was a significant association (p < 0.05) between emotional social support and the following adherence domains: antecedents of non-adherence behaviors and doctor-patient communication. Conclusions: Social support is associated with antecedents of non-adherence behaviors and doctor-patient communication.
RESUMEN Objetivo: Determinar la asociación entre apoyo social, adherencia al tratamiento antirretroviral del VIH y factores clínicos y sociodemográficos. Método: Estudio transversal realizado en una clínica ambulatoria especializada en un municipio del sur de Brasil, desde julio de 2016 hasta agosto de 2018. Se realizaron entrevistas individuales para aplicar los instrumentos Cuestionario para la Evaluación de la Adhesión al Tratamiento Antirretroviral (CEAT-VIH) y la Escala de Apoyo Social para personas que viven con VIH/SIDA. Para el análisis, se utilizó la prueba de correlación bivariada de Spearman. Resultados: Entre los 168 participantes, el apoyo social promedio fue de 3.53 (DE = 0.66), y el 64.9% (n = 109) tuvo un nivel de adherencia insuficiente. Se registró una asociación significativa (p < 0.05) entre el apoyo social emocional y los siguientes dominios de adherencia: antecedente de incumplimiento y comunicación médico-paciente. Conclusiones: El apoyo social se asocia con antecedentes de incumplimiento y comunicación médico-paciente.
RESUMO Objetivo: Verificar associação entre suporte social, adesão ao tratamento antirretroviral para HIV e fatores clínicos e sociodemográficos. Método: Estudo transversal realizado em ambulatório especializado em município na região Sul do Brasil, entre julho de 2016 a agosto de 2018. Foram realizadas entrevistas individuais para aplicação dos instrumentos Cuestionario para la Evaluación de la Adhesión al Tratamiento Antiretroviral (CEAT-VIH) e a Escala de Suporte Social para pessoas vivendo com HIV/AIDS. Para análise utilizou-se o teste de correlação bivariada de Spearman. Resultados: entre os 168 participantes, a média de suporte social foi de 3.53 (DP=0,66) e 64,9% (n=109) apresentaram adesão insuficiente. Houve associação significativa (p < 0,05) entre o suporte social emocional com os domínios da adesão antecedentes de falha de adesão e comunicação médico-paciente. Conclusões: O suporte social é associado com os antecedentes de falta de adesão e a comunicação médico-paciente.
Sujets)
Adulte , Femelle , Humains , Mâle , Soutien social , Infections à VIH/traitement médicamenteux , Antirétroviraux/usage thérapeutique , Adhésion au traitement médicamenteux/statistiques et données numériques , Études transversalesRésumé
RESUMO: Objetivos: Avaliar a não adesão à farmacoterapia de doenças crônicas e investigar a existência de desigualdades socioeconômicas relacionadas a esse desfecho no Brasil. Métodos: Estudo realizado com base em dados da Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM), de 2014. A população de estudo correspondeu a indivíduos com 18 anos ou mais, com diagnóstico médico de pelo menos uma doença crônica e com indicação de tratamento farmacológico. A variável dependente foi a não adesão à farmacoterapia de doenças crônicas, mensurada pela adesão menor que 80% à terapia medicamentosa. Avaliou-se a desigualdade socioeconômica relacionada a não adesão pelos índices absoluto (SII) e relativo (RII) de desigualdade, calculados por análise de regressão logística. Resultados: A prevalência de não adesão à farmacoterapia no Brasil foi de 20,2%, variando de 17 a 27,8% entre as regiões. Além disso, esse estudo revelou desigualdades socioeconômicas absoluta e relativa na não adesão à farmacoterapia de doenças crônicas no Brasil (SII = -7,4; RII = 0,69) e nas regiões Nordeste (SII = -14; RII = 0,59) e Centro-Oeste (SII = -20,8; RII = 0,38). A probabilidade de não adesão à farmacoterapia, no Brasil, é maior entre os indivíduos de pior condição socioeconômica. Conclusão: Os achados do presente estudo apontam a necessidade de reestruturação e fortalecimento das políticas públicas voltadas à redução das desigualdades socioeconômicas em prol da promoção da equidade na adesão à farmacoterapia de doenças crônicas.
ABSTRACT: Objective: To evaluate non-adherence to pharmacotherapy for chronic diseases and to investigate the existence of socioeconomic inequalities related to this outcome in Brazil. Methods: This was a cross-sectional study based on data from the National Survey on Access, Use and Promotion of the Rational Use of Medicines (PNAUM). The study population corresponded to individuals aged 18 years or older with a medical diagnosis of at least one chronic disease and an indication for pharmacological treatment. The dependent variable was non-adherence to chronic disease pharmacotherapy measured by less than 80% adherence to drug therapy. Socioeconomic inequality related to non-adherence was assessed by absolute (SII) and relative (RII) inequality indices, calculated by logistic regression analyses. Results: The prevalence of non-adherence to pharmacotherapy in Brazil was 20.2%, ranging from 17.0 to 27.8% between regions. Furthermore, this study revealed absolute and relative socioeconomic inequalities in non-adherence to pharmacotherapy of chronic diseases in Brazil (SII = -7.4; RII = 0.69) and the Northeast (SII = -14.0; RII = 0.59) and Center West (SII = -20.8; RII = 0.38) regions. The probability of non-adherence to pharmacotherapy in Brazil was higher among individuals with worse socioeconomic status. Conclusion: The findings of the present study indicate the need for the restructuring and strengthening of public policies aimed at reducing socioeconomic inequalities, in order to promote equity in adherence to the pharmacotherapy associated with chronic diseases.
Sujets)
Humains , Adolescent , Adulte , Maladie chronique/traitement médicamenteux , Adhésion au traitement médicamenteux/statistiques et données numériques , Facteurs socioéconomiques , Brésil , Études transversalesRésumé
ABSTRACT Objective To investigate the impact of pharmaceutical care-based interventions on type 2 diabetes mellitus . Methods PubMed®, Cochrane and Web of Science data bases were searched for randomized controlled clinical trials. Studies evaluating pharmaceutical care-based interventions in type 2 diabetes mellitus published between 2012 and 2017 were included. Glycated hemoglobin was defined as the primary endpoint; blood pressure, triglycerides and cholesterol as secondary endpoints. The random effects model was used in meta-analysis. Results Fifteen trials involving 2,325 participants were included. Meta-analysis revealed considerable heterogeneity (I2>97%; p<0.001), reduction in glycated hemoglobin (-1.07%; 95%CI: -1.32; -0.83; p<0.001), glucose (-29.91mg/dL; 95%CI: -43.2; -16.6; p<0.001), triglyceride (19.8mg/dL; 95%CI: -36.6; -3.04; p=0.021), systolic blood pressure (-4.65mmHg; 95%CI: -8.9; -0.4; p=0.032) levels, and increased HDL levels (4.43mg/dL; 95%CI: 0.16; 8.70; p=0.042). Conclusion Pharmaceutical care-based clincal and education interventions have significant impact on type 2 diabetes mellitus . The tools Summary of Diabetes Self-Care Activities and the Morisky Medication Adherence Scale may be useful to monitor patients.
RESUMO Objetivo Identificar o impacto das intervenções providenciadas pelo cuidado farmacêutico no diabetes mellitus tipo 2. Métodos Buscas por ensaios clínicos randomizados controlados foram realizadas nas bases PubMed®, Cochrane e Web of Science . Foram incluídos estudos publicados entre 2012 e 2017, que avaliaram o impacto do cuidado farmacêutico no diabetes mellitus tipo 2. A hemoglobina glicada foi o desfecho primário, e os secundários foram pressão arterial, triglicérides e colesterol. O modelo de efeitos aleatórios foi utilizado na metanálise. Resultados Foram incluídos 15 estudos envolvendo 2.325 participantes. A metanálise demonstrou heterogeneidade elevada (I2>97%; p<0,001), redução nos níveis de hemoglobina glicada (-1,07%; IC95%: -1,32; -0,83; p<0,001), glicose (-29,91mg/dL; IC95%: -43,2; -16,6; p<0,001), triglicérides (19,8mg/dL; IC95%: -36,6; -3,04; p=0,021), pressão arterial sistólica (-4,65mmHg; IC95%: -8,9; -0,4; p=0,032) e aumento do colesterol HDL (4,43mg/dL; IC95%: 0,16; 8,70; p=0,042). Conclusão As intervenções clínicas e educacionais providenciadas pelo cuidado farmacêutico têm impacto significativo no diabetes mellitus tipo 2. Ferramentas como o Summary of Diabetes Self-Care Activities e a Morisky Medication Adherence Scale podem ser úteis no acompanhamento dos pacientes.
Sujets)
Humains , Mâle , Femelle , Sujet âgé , Essais contrôlés randomisés comme sujet , Patients en consultation externe/statistiques et données numériques , Pharmaciens , Services pharmaceutiques/statistiques et données numériques , Autosoins/statistiques et données numériques , Triglycéride/sang , Glycémie/analyse , Pression sanguine , Hémoglobine glyquée/analyse , Cholestérol/sang , Éducation du patient comme sujet/statistiques et données numériques , Diabète de type 2/traitement médicamenteux , Diabète de type 2/sang , Adhésion au traitement médicamenteux/statistiques et données numériques , Adulte d'âge moyenRésumé
Abstract Objective: To identify beliefs related to oral antidiabetic use among individuals with type 2 diabetes mellitus, based on the Theory of Planned Behavior. Method: This is a descriptive, quantitative and qualitative study conducted with 32 participants using oral antidiabetic drugs. Data was collected through an open question tool and analyzed by number of emissions and content. Results: Among the behavioral beliefs, the following stand out: (a) as an advantage, to keep diabetes controlled; and (b) as disadvantages, gastric pain and discomfort, nausea and diarrhea. In the normative beliefs, family stood out as a social referent (children, mother and siblings). As for the control beliefs, taking the tablets with water and the size of the tablets stood out as practicalities and difficulties, respectively, in relation to the oral therapy follow-up. Conclusion and implications for practice: It was possible to identify the beliefs regarding the behavior of taking oral antidiabetics that will contribute to foster educational strategies with the potential to strengthen the positive beliefs and to revert the negative ones, in favor of adherence to drug therapy, glycemic control and quality of life.
Resumen Objetivo: Identificar las creencias relacionadas con el uso de antidiabéticos orales en personas con diabetes mellitus tipo 2, con base en la Teoría de la Conducta Planificada. Método: Estudio descriptivo, con abordaje cuantitativo y cualitativo, realizado con 32 participantes en tratamiento con antidiabéticos orales. Los datos se recolectaron por medio de un formulario con preguntas abiertas y se los analizó por la cantidad de emisiones y el contenido. Resultados: Entre las creencias comportamentales se destacan las siguientes: (a) como ventaja, mantener controlada la diabetes; y (b) como desventajas, dolor y malestar gástrico, náusea y diarrea. En las creencias normativas sobresalió la familia como referente social (hijos, madre y hermanos). En cuanto a las creencias de control, tomar los comprimidos con agua y el tamaño de los comprimidos se destacaron como facilidades y dificultades, respectivamente, en relación con el seguimiento de la terapia oral. Conclusión e implicaciones para la práctica: Fue posible identificar las creencias con respecto a la conducta en el uso de antidiabéticos orales que ayudarán a fomentar estrategias educativas con el potencial de fortalecer las creencias positivas y revertir las negativas, en beneficio de la adhesión a la terapia medicamentosa, del control de la glicemia y de la calidad de vida.
Resumo Objetivo: Identificar as crenças relacionadas ao uso de antidiabético oral em pessoas com diabetes mellitus tipo 2, com base na Theory of Planned Behavior. Método: Estudo descritivo com abordagem quantiqualitativa, realizado com 32 participantes em uso de antidiabético oral. Os dados foram coletados por meio de formulário com perguntas abertas e analisados pelo número de emissões e conteúdo. Resultados: Entre as crenças comportamentais, destacam-se: como vantagem, manter o diabetes controlado; e, como desvantagens, dor e desconforto gástrico, enjoo e diarreia. Nas crenças normativas, sobressaiu como referente social a família (filhos, mãe e irmãos). Quanto às crenças de controle, tomar os comprimidos com água e o tamanho dos comprimidos como as facilidades e dificuldades, respectivamente, em relação ao seguimento da terapêutica oral. Conclusão e implicações para prática: Foi possível identificar as crenças frente ao comportamento da tomada do antidiabético oral que contribuirão para fomentar estratégias educativas com poder de fortalecer as positivas e reverter as negativas, em benefício da adesão à terapêutica medicamentosa, ao controle glicêmico e à qualidade de vida.